Brian Bunn, a partner with international law firm McDermott Will and Emery, shared his perspective on healthcare investment in the runup to the healthcare conference MedCity INVEST in Chicago April 23-24, in which he will take part in a panel discussion on M&A and investment trends.
McDermott Will & Emery partner Kristian Werling is co-chair of the firm’s robust Life Sciences practice. According to Krist, McDermott’s Life Sciences group has “all the tools in the toolkit to help life science entrepreneurs, growth-stage companies and large global companies achieve their patient-centered mission. Hearing patients, helping heal patients and everything in between.” About […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In January 2016, in collaboration with Lake Whillans and our sister site Above the Law, we published the inaugural Life Sciences Law Firm Index to help identify which law firms are the most active and relevant for life science companies. The goal of the Index is to inform innovators about which firms are the leaders in the […]
The life sciences — particularly in biotechnology and pharmaceuticals — are among the very few industries where companies insist on industry-specialized advisors. The complex life cycle of a life sciences product demands a broad range of legal and business expertise across many practice specialties, combined with deep scientific knowledge. The stakes are increasing particularly when […]